Table 1.
Application of three different growth factor-based DM treatments for a time point of four and seven days on three different bone marrow-derived stem cell lines. N/A in column 4 refers to results where none of the cell line samples in DM medium could show a higher expression of MYH11 than cell lines grown in CCM. Only PT (semi-batch) and PT treatment could elicit MYH II expression greater than CCM control in at least one trial.
| Number of Trials | Cell Line | Time Period (Days) | Treatments with MYH11 Expression Greater than Cell Culture Medium Control |
|---|---|---|---|
| 3 | M1–30 Y Female Hispanic | 4 | PDGF + TGF β1 semi batch (1) |
| 3 | M1–30 Y Female Hispanic | 7 | PDGF + TGF β1 semi batch (1) |
| 3 | M2–18 Y Female African | 4 | PDGF + TGF β1 semi batch (1) |
| 3 | M2–18 Y Female African | 7 | N/A (3) |
| 3 | M3–21 Y Male Asian | 4 | PDGF + TGF β1 (1) |
| 3 | M3–21 Y Male Asian | 7 | N/A (3) |